RIGI and hepatocellular carcinoma: The RIG-I N-terminal fragment (RIG-I N) has been previously shown to sufficiently activate the type I IFN response [22] and gene knockdown of ATG5 increased the RIG-I N-induced activation of IFN-β and ISRE promoters in human hepatoma Huh7 cells.